Mounjaro 7.5mg weight loss reviews: what Trustpilot feedback and clinical evidence tell you

Step 1, understanding where 7.5mg sits in the real-world journey

Tirzepatide's licensed schedule starts at 2.5mg for the first four weeks, moves to 5mg for the next four, and then reaches 7.5mg at roughly week nine. That context matters enormously when reading reviews. Someone writing about 7.5mg is probably six to ten weeks into treatment, well past the most turbulent adjustment period, but not yet at the dose where the largest average losses are recorded. If you want to understand what earlier doses felt like, the 5mg experience is worth reading alongside this page.

Most reviews at this stage describe appetite noticeably reduced and early weight changes visible on the scales. The SURMOUNT-1 trial, published in the New England Journal of Medicine, found that participants continued to lose weight at each successive dose level, with the sharpest cumulative losses occurring as doses climbed beyond 7.5mg. A review written at week ten is therefore a snapshot, not a final result. That's not a reason to dismiss it (it tells you something real about tolerability and early momentum) but it does need the trial context to be meaningful.

Trustpilot reviews for any prescription medicine are also self-selected. People who feel well enough to write a review, and motivated enough to seek it out, tend to be different from the full clinical-trial population. Worth keeping in mind.

Step 2, the side-effect picture at 7.5mg, and how to read it in reviews

A question our prescribers hear most weeks: "Is it normal to feel more nauseous after moving from 5mg to 7.5mg?" The short answer is yes, it's common and usually temporary. The NHS tirzepatide guidance describes gastrointestinal effects (nausea, loose stools, constipation, indigestion) as the most frequently reported, typically peaking in the days after a dose change and easing within one to two weeks. Reviews often capture that peak rather than the settled state.

What you'll see less often in public reviews: the people who found the transition smooth. They tend not to write. So the review pool skews toward the noteworthy, which usually means the uncomfortable. That doesn't make the discomfort unreal (it is common) but it also means a cluster of nausea mentions at 7.5mg doesn't necessarily signal that the dose is wrong for you. Anyone whose symptoms feel severe, persistent, or include strong upper-abdominal pain should contact their prescriber promptly rather than waiting for the next scheduled review. For a fuller picture of what to watch for, the Mounjaro overview page covers the safety profile in detail.

Dose increases and side-effect patterns vary enough that tirzepatide dosing decisions should always be led by your prescriber rather than by what worked for someone in a review thread.

Step 3, making sense of weight loss numbers mentioned in reviews

People mention specific numbers in reviews: "I've lost X kg in eight weeks." Those figures are real for that person. They are not predictions for anyone else. Body weight at baseline, calorie intake, how much activity someone does, and whether they have conditions like type 2 diabetes all shift individual responses significantly. SURMOUNT-1's 72-week data (which showed average reductions of around 15% at 10mg and roughly 20–21% at 15mg) represents a carefully monitored group; real-world results cluster around those figures but spread wide in both directions.

At 7.5mg specifically, trial participants were still moving through the titration phase. Published sub-analyses suggest consistent downward weight trends at this level, but the biggest average losses in the SURMOUNT programme accumulated over the full 72 weeks at maintenance doses. If a review at 7.5mg quotes a smaller absolute loss than you were hoping for, the more useful question to ask is whether the trajectory is heading in the right direction, that is something your prescriber can assess from your records, which a Trustpilot review cannot replicate.

For context on how the cost of treatment factors into the overall picture, the Mounjaro pricing guide explains what a legitimate prescription-inclusive price covers, including clinical review at every dose stage, which is what makes those trajectory conversations possible.

Step 4, what to do with this information before your next step

Reading reviews is a reasonable way to know what to expect emotionally and practically. It is not a reliable way to decide whether to move to 10mg, stay at 7.5mg, or change anything else about your treatment. Those calls belong with a prescriber who can see your weight trend, your side-effect history, and your medical background.

If you're on 7.5mg and wondering what the next stage might look like, the 10mg experience is documented separately, including what the evidence says about results at that level. If you're earlier in the process and want to understand what people say about the very first dose, that context is useful too. The broader picture of how people experience the titration across all doses is collected on the 7.5mg reviews hub, which pulls together patterns rather than individual snapshots.

Mounjaro is a prescription medicine, every dose step at nume is reviewed by a GPhC-registered prescriber before it proceeds, not processed automatically. If you'd like to explore whether tirzepatide is clinically appropriate for where you are now, you can speak to our prescribers through a free consultation, with no obligation and no waiting list.